These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36445159)

  • 1. Host Cell Oxidative Stress Promotes Intracellular Fluoroquinolone Persisters of Streptococcus pneumoniae.
    Hernandez-Morfa M; Reinoso-Vizcaíno NM; Olivero NB; Zappia VE; Cortes PR; Jaime A; Echenique J
    Microbiol Spectr; 2022 Dec; 10(6):e0436422. PubMed ID: 36445159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.
    Patel SN; McGeer A; Melano R; Tyrrell GJ; Green K; Pillai DR; Low DE;
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3703-8. PubMed ID: 21628545
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Dao TH; Echlin H; McKnight A; Marr ES; Junker J; Jia Q; Hayden R; van Opijnen T; Isberg RR; Cooper VS; Rosch JW
    mBio; 2024 Feb; 15(2):e0282823. PubMed ID: 38193698
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic Tolerance Indicative of Persistence Is Pervasive among Clinical Streptococcus pneumoniae Isolates and Shows Strong Condition Dependence.
    Geerts N; De Vooght L; Passaris I; Delputte P; Van den Bergh B; Cos P
    Microbiol Spectr; 2022 Dec; 10(6):e0270122. PubMed ID: 36374111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular
    Hernandez-Morfa M; Reinoso-Vizcaino NM; Zappia VE; Olivero NB; Cortes PR; Stempin CC; Perez DR; Echenique J
    Front Microbiol; 2024; 15():1423995. PubMed ID: 39035445
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae.
    Ferrándiz MJ; Martín-Galiano AJ; Arnanz C; Zimmerman T; de la Campa AG
    Antimicrob Agents Chemother; 2016 Jan; 60(1):409-17. PubMed ID: 26525786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.
    Valenzuela MV; Domenech M; Mateos-Martínez P; González-Camacho F; de la Campa AG; García MT
    PLoS One; 2020; 15(11):e0241780. PubMed ID: 33141832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
    Otani T; Tanaka M; Ito E; Kurosaka Y; Murakami Y; Onodera K; Akasaka T; Sato K
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3750-9. PubMed ID: 14638477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
    Zhang FF; Zhao CJ; Wang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations.
    De Vecchi E; Nicola L; Ossola F; Drago L
    J Antimicrob Chemother; 2009 Apr; 63(4):721-7. PubMed ID: 19218275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
    Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
    Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
    BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones].
    Malakhova MV; Vereshchagin VA; Il'ina EN; Govorun VM; Filimonova OIu; Grudinina SA; Sidorenko SV
    Antibiot Khimioter; 2007; 52(1-2):10-7. PubMed ID: 18461803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
    LaPlante KL; Rybak MJ; Tsuji B; Lodise TP; Kaatz GW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1315-20. PubMed ID: 17296740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.